Cargando…
79. Outcomes Associated with the Utilization of the Methicillin-Resistant Staphylococcus aureus (MRSA) Nasal Polymerase Chain Reaction (PCR) Assay to De-escalate Vancomycin Therapy in Patients with Suspected Pneumonia at a Rural Community Hospital
BACKGROUND: Vancomycin is often added to standard inpatient community acquired pneumonia therapy, but the incidence of MRSA pneumonia is relatively low. The MRSA nasal PCR assay is used to detect if a patient’s nares are colonized with MRSA. Studies have found that this test has an excellent negativ...
Autores principales: | Tirupathi, Raghavendra, Kyner, Mackenzie, Logsdon, Jarett |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7777228/ http://dx.doi.org/10.1093/ofid/ofaa439.124 |
Ejemplares similares
-
79. Clinical Utility of Methicillin-Resistant Staphylococcus aureus (MRSA) Nasal PCR Assays Beyond Respiratory Infections
por: Noeldner, Haley M, et al.
Publicado: (2021) -
Use of nares swab to de-escalate vancomycin for patients with suspected methicillin-resistant Staphylococcus aureus
por: Gentges, Joshua, et al.
Publicado: (2023) -
1266. Refining Antimicrobial Stewardship by De-escalating Vancomycin Using MRSA (Methicillin Resistant Staphylococcus aureus) Nasal Screening in a Community Hospital Setting
por: Shah, Ruta, et al.
Publicado: (2023) -
Discontinuation Patterns and Cost Avoidance of a Pharmacist-Driven Methicillin-Resistant Staphylococcus aureus Nasal Polymerase Chain Reaction Testing Protocol for De-escalation of Empiric Vancomycin for Suspected Pneumonia
por: Meng, L, et al.
Publicado: (2021) -
2003. Vancomycin Discontinuation Is Supported by-negative Nasal Methicillin-Resistant Staphylococcus aureus (MRSA) in Patients with Pneumonia
por: Pleasants, Katherine A, et al.
Publicado: (2019)